Adlai Nortye (ANL) Stock Chart & Stock Price History $1.58 +0.03 (+1.61%) Closing price 03:58 PM EasternExtended Trading$1.58 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Adlai Nortye Stock Price Performance The Adlai Nortye (ANL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 50.78%, with a year-to-date return of -41.45%. In the past month, the stock has decreased 0.32%, reflecting recent market activity. As of the latest close, Adlai Nortye traded at $1.54 with a market cap of $56.64 million and volume of 9,648 shares. Receive ANL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+8.25%1 Month Performance-0.32%3 Month Performance-14.40%Year-To-Date Performance-41.45%1 Year Performance-50.78% ANL Stock Chart for Friday, August, 8, 2025 ANL Chart by TradingView Adlai Nortye Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$1.54$1.58+2.61%$1.64$1.525,416 shs$58.12 million08/07/2025$1.57$1.54-2.29%$1.61$1.469,648 shs$56.64 million08/06/2025$1.50$1.57+4.73%$1.55$1.502,796 shs$57.97 million08/05/2025$1.50$1.50$1.55$1.436,787 shs$55.35 million08/04/2025$1.46$1.50+3.09%$1.52$1.438,799 shs$55.35 million08/01/2025$1.43$1.46+1.75%$1.47$1.434,210 shs$53.69 million07/31/2025$1.43$1.43$1.45$1.4110,693 shs$52.77 million07/30/2025$1.43$1.43+0.11%$1.42$1.411,277 shs$52.77 million07/29/2025$1.42$1.43+0.95%$1.45$1.413,652 shs$52.71 million07/28/2025$1.44$1.42-1.74%$1.47$1.418,315 shs$52.21 million Get the Latest News and Ratings for ANL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$1.47$1.44-2.04%$1.49$1.436,949 shs$53.14 million07/24/2025$1.47$1.47$1.52$1.475,897 shs$54.24 million07/23/2025$1.56$1.47-5.71%$1.55$1.4716,766 shs$54.24 million07/22/2025$1.52$1.56+2.57%$1.55$1.52911 shs$57.53 million07/21/2025$1.52$1.52$1.55$1.503,546 shs$56.09 million07/18/2025$1.50$1.52+1.33%$1.52$1.504,448 shs$56.09 million07/17/2025$1.52$1.50-0.99%$1.53$1.503,911 shs$55.35 million07/16/2025$1.57$1.52-3.50%$1.55$1.512,271 shs$55.90 million07/15/2025$1.51$1.57+3.97%$1.57$1.56669 shs$57.93 million07/14/2025$1.61$1.51-6.18%$1.63$1.4823,793 shs$55.72 million07/11/2025$1.55$1.61+3.83%$1.61$1.55647 shs$59.39 million07/10/2025$1.57$1.55-1.19%$1.60$1.5011,687 shs$57.20 million07/09/2025$1.58$1.57-0.72%$1.57$1.571,572 shs$57.88 million07/08/2025$1.42$1.58+11.27%$1.58$1.51983 shs$58.30 million07/07/2025$1.57$1.42-9.32%$1.63$1.4224,823 shs$52.40 million Related Companies CARGO Therapeutics Stock Price Chart Neoleukin Therapeutics Stock Price Chart enGene Stock Price Chart Aerovate Therapeutics Stock Price Chart Innate Pharma Stock Price Chart MediWound Stock Price Chart GENFIT Stock Price Chart Semper Paratus Acquisition Stock Price Chart Eupraxia Pharmaceuticals Stock Price Chart DiaMedica Therapeutics Stock Price Chart Receive ANL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adlai Nortye and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adlai Nortye Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Adlai Nortye With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
